27 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
(nn) Cybersecurity
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
regarding the Company or its Subsidiaries or their financial results or prospects.
(nn) Cybersecurity. (i)(x) There has been no security breach
8-K
EX-10.1
kk5zhg
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
424B5
wnfn19u
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
rz3zc0 2k
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
jc5ijo82 n1k
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
tci984u9h45m4s h1
7 Apr 22
Prospectus supplement
4:46pm
S-3
jsb4h umklxmi
4 Feb 22
Shelf registration
4:36pm
10-K
0wlk3yc0l21fs kh65rq
24 Sep 21
Annual report
7:31am
424B3
qi0gc
22 Jul 21
Prospectus supplement
10:27am
424B3
nwl4aa60wfw6jw393zb0
16 Mar 21
Prospectus supplement
12:00am
10-Q
khtd3 166yxhb
17 Dec 20
Quarterly report
12:00am
424B4
5vp50mylr8mxx 5w
13 Nov 20
Prospectus supplement with pricing info
8:52pm